RON D， HUBBARD S R. How IRE1 reacts to ER stress[J]. Cell, 2008, 132(1): 24-26.
[2]
BACK S H, SCHRODER M, LEE K, et al. ER stress signaling by regulated splicing: IRE1/HAC1/XBP1[J]. Methods, 2005, 35(4): 395-416.
[3]
ZHANG K, KAWAUCHI J, ADACHI M T, et al. Activation of JNK and transcriptional repressor ATF3/LRF1 through the IRE1/TRAF2 pathway is implicated in human vascular endothelial cell death by homocysteine[J]. Biochem Biophys Res Commun, 2001, 289(3): 718-724.
[4]
TIROSPHORON W, WELIHINDA A A, KAUFMAN R J. A stress response pathway from the endoplasmic reticulum to the nucleus requires a novel bifunctional protein kinase/endoribonuclease (Ire1p) in mammalian cells[J]. Genes Dev, 1998, 12(12): 1812-1824.
[5]
PAPA F R, ZHANG C, SHOKAT K, et al. Bypassing a kinase activity with an ATP-competitive drug[J]. Science, 2003, 302(5650): 1533-1537.
[6]
HAN D, UPTON J P, HAGAN A, et al. A kinase inhibitor activates the IRE1alpha RNase to confer cytoprotection against ER stress[J]. Biochem Biophys Res Commun, 2008, 365(4): 777-783.
[7]
MAO T, SHAO M L, QIU Y F, et al. PKA phosphorylation couples hepatic inositol-requiring enzyme 1alpha to glucagon signaling in glucose metabolism[J]. Proc Natl Acad Sci USA, 2011, 108(38): 15852-15857.
[8]
LEE H, NOH J Y, OH Y, et al. IRE1 plays an essential role in ER stress-mediated aggregation of mutant huntingtin via the inhibition of autophagy flux[J]. Hum Mol Genet, 2012, 21(1): 101-114.
[9]
DROGAT B, AUGUSTE P, NGUYEN D T, et al., IRE1 signaling is essential for ischemia-induced vascular endothelial growth factor-A expression and contributes to angiogenesis and tumor growth in vivo[J]. Cancer Res, 2007, 67(14): 6700-6707.
[10]
AUF G, JABOUILLE A, GUERIT S, et al. Inositol-requiring enzyme 1alpha is a key regulator of angiogenesis and invasion in malignant glioma[J]. Proc Natl Acad Sci USA, 2010, 107(35): 15553-15558.
[11]
VOLKMANN K, LUCAS J L, VUGA D, et al. Potent and selective inhibitors of the inositol-requiring enzyme 1 endoribonuclease[J]. J Biol Chem, 2011, 286(14): 12743-12755.
[12]
WALSH D. Cloning PCR products for sequencing in M13 vectors[J]. Methods Mol Biol, 2003, 226: 385-392
[13]
IVESEN P W, EASTWOOD B J, SITTA G, et al. A comparison of assay performance measures in screening assays: signal window, Z’ factor, and assay variability ratio[J]. Journal of Biomolecular Screening, 2006, 11(3): 247-252.
[14]
ALI M M, BAGRATUNI T, DAVENPORT E L, et al. Structure of the Ire1 autophosphorylation complex and implications for the unfolded protein response[J]. Embo J, 2011, 30(5): 894-905.
[15]
HABERT C, MARSHALL J, SOH S, et al. Development of a HTRF kinase assay for determination of Syk activity[J]. Curr Chem Genomics, 2008（1）: 20-26.
[16]
ZEGZOUTI H, ZDANOVSKAIA M, HSIAO K, et al. ADP-Glo: A Bioluminescent and homogeneous ADP monitoring assay for kinases[J]. Assay Drug Dev Technol, 2009, 7(6): 560-572.
[17]
KORESAWA M， OKABE T. High-throughput screening with quantitation of ATP consumption: a universal non-radioisotope, homogeneous assay for protein kinase[J]. Assay Drug Dev Technol, 2004, 2(2): 153-160.
